Physician profile

Nathan Laufer

Cardiovascular Disease · Phoenix, AZ

NPI 1871587048

$15,063.91

in general payments reported to CMS, 2019-2025

54 companies · $1,505 in 2025

The $1,505 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,052.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,954.57 2019-2025 Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Lithovue Empower
Medtronic Vascular, INC. $1,351.30 2019-2020
Novartis Pharmaceuticals Corporation $1,202.53 2019-2025
Biotronik INC. $1,146.22 2019-2024 Amvia Edge
Abbott Laboratories $1,065.23 2019-2025 Cardiomems
Impulse Dynamics (USA) INC. $997.32 2021-2022
Kestra Medical Technology Services, INC. $644.54 2022-2025 Assure Wcd
Medtronic, INC. $542.28 2021-2025 Micra, Endurant Iis, Azure Xt Dr Mri Surescan
Janssen Pharmaceuticals, INC $523.80 2019-2022
Edwards Lifesciences Corporation $523.39 2019-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve
Abiomed $437.67 2022-2024 Impella
Amgen INC. $308.74 2019-2024 Repatha
Atricure, INC. $292.93 2023-2024
Tactile Systems Technology INC $289.42 2022-2024 Flexitouch Plus, Entre Plus
Amarin Pharma, INC. $280.72 2019
Show all 54 companies
CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $267.82 2019-2025 Lifevest
Merck Sharp & Dohme LLC $258.28 2021-2022
Astrazeneca Pharmaceuticals LP $236.34 2021
Penumbra, INC. $203.48 2019-2023 Indigo System
Nuwellis, INC. $170.03 2022
Angiodynamics, INC. $166.23 2020-2023 Auryon Laser System 100-120 Vac
Bardy Diagnostics, INC. $165.00 2019-2022
Pfizer INC. $160.07 2019-2022
Scpharmaceuticals INC. $156.94 2023
Lexicon Pharmaceuticals, INC. $124.99 2024 Inpefa
Ekos Corporation $124.91 2019
Bayer Healthcare Pharmaceuticals INC. $116.20 2025
Novo Nordisk INC $112.61 2021-2025 Wegovy, Ozempic
Cmp Pharma, INC. $107.23 2021-2025 Atorvaliq, Tadliq, Liqrev
Eisai INC. $100.27 2025
E.R. Squibb & Sons, L.L.C. $91.81 2019-2022
Philips North America LLC $88.68 2020-2022
Heartflow, INC. $79.87 2023 Ffrct
Actelion Pharmaceuticals US, INC. $77.00 2022
Kowa Pharmaceuticals America, INC. $73.64 2019-2021
Boehringer Ingelheim Pharmaceuticals, INC. $73.17 2023-2025 Jardiance
Cvrx, INC. $60.93 2020
Chiesi USA, INC. $45.70 2019-2021
Cleerly, INC. $44.38 2025 Cleerly Ischemia, Cleerly Labs
Esperion Therapeutics, INC. $41.90 2021-2022
Cardiovascular Systems INC. $38.39 2019
Biosense Webster, INC. $37.86 2023 Carto 3
Medicomp INC $37.55 2019
Itamar Medical INC $34.99 2024-2025 Watchpatone
Regeneron Healthcare Solutions, INC. $28.10 2019
Cordis US Corp. $25.28 2025
Recor Medical INC $24.55 2024 Paradise Renal Denervation System
Inspire Medical Systems, INC. $23.25 2025 Inspire
Baxter Healthcare $21.87 2025 Hillrom - Carnation Ambulatory Monitor
Lundbeck LLC $20.06 2021
Vifor Pharma, INC. $17.51 2019
Kiniksa Pharmaceuticals, LTD. $17.34 2021
Astellas Pharma US INC $17.31 2020
Cardinal Health 200 LLC $11.71 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Nathan Laufer

$15,063.91

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,505 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/176291/nathan-laufer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.